Healmusz Hemorrhoid Fissure

Manufacturer
Jiangxi Hemei Pharmaceutical Co., Ltd
Effective date
2025-09-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 20:34:24

Label at a glance#

ProductHealmusz Hemorrhoid Fissure
Active ingredientPHENYLEPHRINE HYDROCHLORIDE, LIDOCAINE
Label structure13 sections

Dosage and administration

Adults: apply to affected area up to 3 times daily.Clean affected area with mild soap and warm water, rinse thoroughly, and then gently dry (patting or blotting) with tissue or soft cloth before use. To use dispensing cap, attach it to tube, lubricate well then gently insert part way into anus and squeeze tube to deliver medication. Thoroughly cleanse dispensing cap after use with mild soap and warm water and rins...

Storage and handling

If pregnant or breast-feeding, ask a health care professional before use.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Phenylephrine HCl 0.25%

Purpose

OTC - PURPOSE SECTION

Analgesic (pain relief) Vasoconstrictor

Use

INDICATIONS & USAGE SECTION

For external use only including the skin of the anal canal

Warnings

WARNINGS SECTION

When using this product do not exceed recommended daily dosage unless directed by a doctor, when using finger cots or an applicator, apply externally or the skin of the anal canal only.

Do not use

OTC - DO NOT USE SECTION

Do not put this product into the rectum.

When Using

OTC - WHEN USING SECTION

When using this product do not exceed recommended daily dosage unless directed by a doctor, when using finger cots or an applicator, apply externally or the skin of the anal canal only.

Stop Use

OTC - STOP USE SECTION

Ask a doctor before use if you have allergies to any of the components of this product, difficulty in urination due to enlargement of the prostate gland, diabetes, heart disease, high blood pressure, thyroid disease, or presently taking a prescription for high blood pressure or depression.

Ask Doctor

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if condition worsens or does not improve within seven days, bleeding occurs, an allergic reaction develops, thesymptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, seek medical help or contact a Poison Control Center

Directions

DOSAGE & ADMINISTRATION SECTION

Adults: apply to affected area up to 3 times daily.Clean affected area with mild soap and warm water, rinse thoroughly, and then gently dry (patting or blotting) with tissue or soft cloth before use.
To use dispensing cap, attach it to tube, lubricate well then gently insert part way into anus and squeeze tube to deliver medication. Thoroughly cleanse dispensing cap after use with mild soap and warm water and rinse thoroughly.

Other information

STORAGE AND HANDLING SECTION

If pregnant or breast-feeding, ask a health care professional before use.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Borneol,Carbomer Homopolymer,Chlorhexidine Acetate Glycerin,Thymol

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

44

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84010-00184010-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a47d33a-e526-fbed-e063-6394a90ae2ee0f30035f-8c85-8030-e063-6294a90a9ae02026-02-07WarningsExact identifier
spl set id: 0f30035f-8c85-8030-e063-6294a90a9ae0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.